Who we are

Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from member research organisations, providing both capital and expertise to guide the successful development of new therapies.

Brandon BioCatalyst is a unique collaboration of investors, CSL, government and more than 50 leading medical research institutes and hospitals united by a single purpose: generating cutting edge, next generation medical therapies and technologies to improve health and save lives.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    NSW Government Health
    Government of South Australia
    Queensland Government
    Victorian Government
    Western Australian Government
    Ministry of Business, Innovation & Employment (MBIE) NZ

    Management

    Brandon Capital

    Independent Governance
    Investors

    Australian Government
    Australian Super
    Hesta
    Host Plus
    TelstraSuper
    CSL

Members

Institute
La Trobe Institute For Molecular Science (LIMS)

Making translatable molecular discoveries.

View
Institute
Melbourne Health

Melbourne Health’s research vision is to be a leading centre for to delivery of translational health, research and education.

View
Institute
Peter MacCallum Cancer Centre

Peter Mac is one of the world’s leading cancer research, education and treatment centres globally and is Australia’s only public hospital solely dedicated to caring for people affected by cancer. There are over 2,500 staff, including more than 600 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.

View

Government Partners

Investors

Brandon BioCatalyst's investors are AustralianSuper, HESTA, HOSTPLUS, TelstraSuper, CSL and the Australian Government under its IIF and BTF programs.

Brandon Capital

Brandon Capital manages Brandon BioCatalyst, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Brandon Capital website